← back to search

Lei Yan

Shandong University · CN
Area of research
Molecular Biology · Epidemiology
Research interest
Research focused on microRNA and Cancer research, with related work in Pathogenesis, Cancer, Pancreatic cancer. Notable publications include 'Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis', 'Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs)', and 'Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway'.
h-index
citations
1,822
works
7
NIH funding
primary concept
email

Recent publications

PSME2 offers value as a biomarker of M1 macrophage infiltration in pan-cancer and inhibits osteosarcoma malignant phenotypes
International Journal of Biological Sciences 2024cited by 24position: middledoi
A new method for purifying Brazilin from lignum sappan – Cytotoxic and anti-proliferative effects in cell lines and improved survival in mice bearing urinary bladder carcinoma
Pharmacognosy Magazine 2020cited by 3position: middledoi
Transcriptomic landscape regulated by the 14 types of bone morphogenetic proteins (BMPs) in lineage commitment and differentiation of mesenchymal stem cells (MSCs)
Genes & Diseases 2019cited by 96position: middledoi
A simplified system for the effective expression and delivery of functional mature microRNAs in mammalian cells
Cancer Gene Therapy 2019cited by 57position: middledoi
Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells
ACS Synthetic Biology 2019cited by 29position: middledoi
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Genes & Diseases 2018cited by 1,480position: middledoi
Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway
Scientific Reports 2018cited by 83position: middledoi
A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions
Molecular Therapy — Nucleic Acids 2018cited by 45position: middledoi
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
Infection and Drug Resistance 2018cited by 32position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Linghuan Zhang · Dalian Medical University2 papers (2018–2019)Hue H. Luu · University of Chicago Medical Center2 papers (2018–2019)Zongyue Zeng · Brown University2 papers (2018–2019)Rex C. Haydon · University of Chicago2 papers (2018–2019)Yixiao Feng · Dalian Medical University2 papers (2018–2019)Huanhu Zhang · Fudan University1 papers (2020–2020)Jennifer Moriatis Wolf · University of Maryland, Baltimore1 papers (2019–2019) · 1 papers (2018–2018)Chuanwu Zhu · Soochow University1 papers (2018–2018)Haifeng Liu · Southwest University of Science and Technology1 papers (2024–2024)Bo Zhang · North Sichuan Medical University1 papers (2019–2019)Jing Li · Capital Medical University1 papers (2018–2018)Jing Zhang · University of Wisconsin–Madison1 papers (2024–2024)Bin Liu · Zhujiang Hospital1 papers (2019–2019)Xian Chen · Guangzhou University of Chinese Medicine1 papers (2019–2019)Xi Wang · Beijing Forestry University1 papers (2019–2019)Wenping Luo · Southwest University1 papers (2018–2018)Guosheng Ren · Molecular Oncology (United States)1 papers (2018–2018)Hui Wang · Fudan University1 papers (2018–2018)Xiaoke Li · Shanxi Medical University1 papers (2024–2024)